NEW YORK (GenomeWeb News) – Strand Genomics and BioHealth Innovation today announced a strategic partnership to expand the Strand Centers for Genomics and Personalized Medicine into the US.

As part of the deal, BHI will connect Strand with "key" market channels, providing patients and healthcare providers with access to genomic services. Based in Rockville, Md., BHI describes itself as an "innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.